These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12115215)

  • 21. Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus.
    Nambiar MP; Fisher CU; Warke VG; Krishnan S; Mitchell JP; Delaney N; Tsokos GC
    Arthritis Rheum; 2003 Jul; 48(7):1948-55. PubMed ID: 12847689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune cell signaling and gene transcription in human lupus: the time has come.
    Tsokos GC
    Int Rev Immunol; 2004; 23(3-4):221-4. PubMed ID: 15204085
    [No Abstract]   [Full Text] [Related]  

  • 23. Defects in Notch1 upregulation upon activation of T Cells from patients with systemic lupus erythematosus are related to lupus disease activity.
    Sodsai P; Hirankarn N; Avihingsanon Y; Palaga T
    Lupus; 2008 Jul; 17(7):645-53. PubMed ID: 18625637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissecting the molecular mechanisms of TCR zeta chain downregulation and T cell signaling abnormalities in human systemic lupus erythematosus.
    Nambiar MP; Juang YT; Krishnan S; Tsokos GC
    Int Rev Immunol; 2004; 23(3-4):245-63. PubMed ID: 15204087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Signal transduction abnormalities in systemic lupus erythematosus].
    Nagy G; Géher P; Koncz A; Perl A
    Orv Hetil; 2005 Jul; 146(31):1625-30. PubMed ID: 16158611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune cell biochemical abnormalities in systemic lupus erythematosus.
    Liossis SN; Vassilopoulos D; Kovacs B; Tsokos GC
    Clin Exp Rheumatol; 1997; 15(6):677-84. PubMed ID: 9444427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biomarkers in systemic lupus erythematosus: II. Markers of disease activity.
    Illei GG; Tackey E; Lapteva L; Lipsky PE
    Arthritis Rheum; 2004 Jul; 50(7):2048-65. PubMed ID: 15248202
    [No Abstract]   [Full Text] [Related]  

  • 28. Responsiveness of systemic lupus erythematosus T cells to signals provided through LCA T200 (CD45) and T1 (CD5) antigens.
    Martorell J; Font J; Rojo I; Vilella R; Ingelmo M; Vives J
    Clin Exp Immunol; 1989 Nov; 78(2):172-6. PubMed ID: 12412744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
    Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of CD70 and overstimulation of IgG synthesis by lupus T cells and T cells treated with DNA methylation inhibitors.
    Oelke K; Lu Q; Richardson D; Wu A; Deng C; Hanash S; Richardson B
    Arthritis Rheum; 2004 Jun; 50(6):1850-60. PubMed ID: 15188362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T cells and the loss of immunologic tolerance in Sjögren's syndrome and systemic lupus erythematosus.
    Hoffman RW
    Arthritis Rheum; 2007 Oct; 56(10):3180-2. PubMed ID: 17907162
    [No Abstract]   [Full Text] [Related]  

  • 32. Signaling in human lupus T lymphocytes.
    Zouali M
    Lupus; 1998; 7(8):499-502. PubMed ID: 9863889
    [No Abstract]   [Full Text] [Related]  

  • 33. Altered signal transduction in SLE T cells.
    Tenbrock K; Juang YT; Kyttaris VC; Tsokos GC
    Rheumatology (Oxford); 2007 Oct; 46(10):1525-30. PubMed ID: 17586862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T cell abnormalities in systemic lupus erythematosus.
    Takeuchi T; Tsuzaka K; Abe T; Yoshimoto K; Shiraishi K; Kameda H; Amano K
    Autoimmunity; 2005 Aug; 38(5):339-46. PubMed ID: 16227148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased ubiquitination and reduced expression of LCK in T lymphocytes from patients with systemic lupus erythematosus.
    Jury EC; Kabouridis PS; Abba A; Mageed RA; Isenberg DA
    Arthritis Rheum; 2003 May; 48(5):1343-54. PubMed ID: 12746907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-nucleosome antibodies and T-cell response in systemic lupus erythematosus.
    Fournel S; Muller S
    Ann Med Interne (Paris); 2002 Dec; 153(8):513-9. PubMed ID: 12610425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered expression of the T cell receptor-CD3 complex in systemic lupus erythematosus.
    Takeuchi T; Tsuzaka K; Abe T
    Int Rev Immunol; 2004; 23(3-4):273-91. PubMed ID: 15204089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship.
    Wouters CH; Diegenant C; Ceuppens JL; Degreef H; Stevens EA
    Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SiLEncing SLE: the power and promise of small noncoding RNAs.
    Rigby RJ; Vinuesa CG
    Curr Opin Rheumatol; 2008 Sep; 20(5):526-31. PubMed ID: 18698172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alterations in the expression of signal-transducing CD3 zeta chain in T cells from patients with chronic inflammatory/autoimmune diseases.
    Ciszak L; Pawlak E; Kosmaczewska A; Potoczek S; Frydecka I
    Arch Immunol Ther Exp (Warsz); 2007; 55(6):373-86. PubMed ID: 18060371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.